Metoprolol Succinate Tablet, Extended Release
Product Images NDC 72516-028

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 72516-028). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Oryza Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Metaprolol 01)

Chemical structure of metoprolol succinate showing the molecular components including the metoprolol moiety and the succinate part as indicated by the carboxyl groups and carbon chains.*

FDA Label Image

Figure (Metaprolol 02)

A forest plot chart titled 'Results for Subgroups in MERIT-HF' showing relative risk and 95% confidence intervals for various subgroups. The chart compares outcomes between metoprolol succinate extended-release tablets and placebo across three endpoints: total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure. Subgroups include geographic region, NYHA class, ejection fraction levels, ischemic etiology, sex, race, myocardial infarction history, diabetes status, hypertension status, and heart rate categories.*

FDA Label Image

50 mg 1000 Count (Metoprolol 09)

Label for Metoprolol Succinate Extended-Release Tablets 50 mg by Oryza Pharmaceuticals Inc. This label indicates a bulk package of 1000 tablets. It includes a warning that the package is not intended for dispensing and details the tablet's equivalent metoprolol succinate content. Manufacturer and distributor addresses in China and the USA are shown, along with storage instructions and a barcode.*

FDA Label Image

100 mg 1000 Count (Metoprolol 10)

Metoprolol Succinate Extended-Release Tablets 100 mg bulk package label from Oryza Pharmaceuticals Inc. The label indicates 1000 tablets in the container, with NDC 72516-027-10. It includes storage instructions, a barcode, and a warning that this is a bulk package and not intended for dispensing.*

FDA Label Image

200 mg 100 Count (Metoprolol 11)

Label for Metoprolol Succinate Extended-Release Tablets 200 mg, oral medication in tablet form, containing 100 tablets per package. The label includes the NDC 72516-028-01, states Rx only, and features the Oryza Pharmaceuticals Inc. logo. Manufacturing details and barcode are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.